The 22nd Awaji International Forum on Infection and Immunity

○Takuya Hemmi¹, Rin Shirota¹, Hisano Yajima¹, Sora Ishikawa^2,3, Yukihiko Sugita^4,5, Akira Ainai^2,3, Takeshi Noda⁴, Tadaki Suzuki², Takao Hashiguchi¹ (1. Laboratory of Medical Virology, Institute for Life and Medical Sciences, Kyoto University (Japan), 2. Department of Pathology, National Institute of Infectious Diseases (Japan), 3. Department of Biological Science and Technology, Tokyo University of Science (Japan), 4. Laboratory of Ultrastructural Virology, Institute for Life and Medical Sciences, Kyoto University (Japan), 5. Hakubi Center for Advanced Research, Kyoto University (Japan))

○Po-hung Wang¹, Kazuo Yamashita¹ (1. KOTAI Biotechnologies, Inc. (Japan))

○David Geoffrey Priest¹, Takeshi Ebihara^3,2, Tulyeu Janyerkye², Søndergaard N. Jonas², Shuhei Sakakibara^5,6, Fuminori Sugihara^7,8, Hiroshi Ogura^3,2, Yumi Mitsuyama^3,9, Jun Oda^2,3, Daisuke Okusaki^2,10,11,12, Hisatake Matsumoto^2,3, James B. Wing^1,4,13 (1. Laboratory of Human Single Cell Immunology, World Premier International Research Center Initiative Immunology Frontier Research Center (WPI-IFReC), Osaka University, Suita, Osaka 563-0793, Japan. (Japan), 2. Center for Infectious Disease Education and Research (CiDER), Osaka University, Suita, Osaka 565-0871, Japan. (Japan), 3. Department of Traumatology and Acute Critical Medicine, Osaka University Graduate School of Medicine, Suita, Osaka 565-0871, Japan. (Japan), 4. Human Single Cell Immunology Team, Center for Infectious Disease Education and Research (CiDER), Osaka University, Suita, Osaka 565-0871, Japan. (Japan), 5. Laboratory of Immune Regulation, IFReC, Osaka University, Suita, Osaka 563-0793, Japan. (Japan), 6. Graduate School of Medical Safety Management, Jikei University of Health Care Sciences, Osaka 532-0003, Japan. (Japan), 7. Core Instrumentation Facility, Immunology Frontier Research Center and Research Institute for Microbial Disease, Osaka University, Suita, Osaka 563-0793, Japan (Japan), 8. Research Institute for Microbial Disease, Osaka University, Suita, Osaka 563-0793, Japan (Japan), 9. Division of Trauma and Surgical Critical Care, Osaka General Medical Center, Osaka 558-8558, Japan (Japan), 10. Laboratory of Human Immunology (Single Cell Genomics), WPI-IFReC, Osaka University, Suita 565-0871, Japan. (Japan), 11. Genome Information Research Center, Research Institute for Microbial Diseases, Osaka University, Suita 565-0871, Japan. (Japan), 12. Integrated Frontier Research for Medical Science Division, Institute for Open and Transdisciplinary Research Initiatives, Osaka University, Suita 565-0871, Japan. (Japan), 13. Center for Advanced Modalities and DDS (CAMaD), Osaka University, Osaka, Japan. (Japan))

Guilherme Melo¹, Carlos Barbosa¹, ○Fabio Re¹ (1. Rosalind Franklin University of Medicine and Science (United States of America))

○Burcu Temizoz^1,2,6,7,8, Nobuyoshi Kobayashi^2,3,8, Yuta Ohira^2,3,8, Areej Sakkour¹, Kou Hioki¹, Mai Onaga¹, Tomoya Hayashi^1,2,6,7, Michelle Sue Jann Lee^5,6, Takayuki Horii³, Cevayir Coban^4,5,6,7, Kouji Kobiyama^1,2,6,7, Ken J Ishii^1,2,4,6,7 (1. Division of Vaccine Science, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan (Japan), 2. Center for Adjuvant and Vaccine Research, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), 7-6-8, Osaka, Japan (Japan), 3. Central Research Laboratories, Zeria Pharmaceutical Co., Ltd., 2512-1 Numagami, Oshikiri, Kumagaya-shi, Saitama, Japan (Japan), 4. WPI Immunology Frontier Research Center (IFReC), Osaka University, 3-3-1, Osaka, Japan (Japan), 5. Division of Malaria Immunology, Department of Microbiology and Immunology, The Institute of Medical Science (IMSUT), The University of Tokyo, 4-6-1, Tokyo, Japan (Japan), 6. International Vaccine Design Center (VDesC), The Institute of Medical Science (IMSUT), The University of Tokyo, 4-6-1, Tokyo, Japan (Japan), 7. The University of Tokyo Pandemic Preparedness, Infection and Advanced Research Center (UTOPIA), The University of Tokyo, Tokyo 108-8639, Japan. (Japan), 8. These authors contributed equally. (Japan))

Nelly M. Silva¹, Ana S. Martins¹, Nina E. Karguth¹, Francisco J. Enguita¹, Roland G. Huber², Nuno C. Santos¹, ○Ivo C. Martins¹ (1. Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, 1649-028 Lisbon, Portugal (Portugal), 2. Bioinformatics Institute (BII), Agency for Science, Technology and Research (A*STAR), 138671 Singapore, Singapore (Singapore))